2. Academic Validation
  3. Practical Total Synthesis of (2S,3S,4R)-1-O-(α-D-Galactopyranosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, the Antitumorial and Immunostimulatory α-Galactosylcer-amide, KRN7000

Practical Total Synthesis of (2S,3S,4R)-1-O-(α-D-Galactopyranosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, the Antitumorial and Immunostimulatory α-Galactosylcer-amide, KRN7000

  • Biosci Biotechnol Biochem. 1996 Jan;60(2):288-92. doi: 10.1271/bbb.60.288.
M Morita 1,  E Sawa 1,  K Yamaji 1,  T Sakai 1,  T Natori 1,  Y Koezuka 1,  H Fukushima 1,  K Akimoto 1
Affiliations

Affiliation

  • 1 a Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., , 3 Miyahara-cho, Takasaki-shi, Gunma 370-12 , Japan.
PMID: 27299402 DOI: 10.1271/bbb.60.288
Abstract

A practical total synthesis of (2S,3S,4R)-l-O-(α-d-galactopyranosyl)-N-hexacosanoyl-2-amino-l,3,4-octadecanetriol (KRN7000), an antitumorial and immunostimulatory glycosphingolipid derived from agelasphins, was achieved in 14 steps starting from d-lyxose in a 16% overall yield.

Keywords

D-lyxose; KRN7000; agelasphins; practical total synthesis; α-galactosylceramide.

Figures
Products